Literature DB >> 26116335

Ebola virus disease: What clinicians in the United States need to know.

William A Fischer1, Timothy M Uyeki2, Robert V Tauxe2.   

Abstract

In March 2014 the World Health Organization was notified of an outbreak of Ebola virus disease (EVD) in the forest region of Guinea. As of May 2015, the outbreak had become the most devastating EVD epidemic in history with more than 27,000 cases and more than 11,000 deaths. The introduction of EVD into noncontiguous countries, including the United States, from infected travelers highlights the importance of preparedness of all health care providers. Early identification and rapid isolation of patients suspected with EVD is critical to limiting the spread of Ebola virus. Additionally, enhanced understanding of EVD case definitions, clinical presentation, treatment procedures, and infection control strategies will improve the ability of health care workers to provide safe care for patients with EVD.
Copyright © 2015 Association for Professionals in Infection Control and Epidemiology, Inc. All rights reserved.

Entities:  

Keywords:  Person under investigation; Personal protection equipment; Viral hemorrhagic fever

Mesh:

Year:  2015        PMID: 26116335      PMCID: PMC4523406          DOI: 10.1016/j.ajic.2015.05.005

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  30 in total

Review 1.  Ebola and Marburg viruses: pathogenesis and development of countermeasures.

Authors:  Lisa E Hensley; Steven M Jones; Heinz Feldmann; Peter B Jahrling; Thomas W Geisbert
Journal:  Curr Mol Med       Date:  2005-12       Impact factor: 2.222

2.  Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team.

Authors: 
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

3.  Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections.

Authors:  N M Kudoyarova-Zubavichene; N N Sergeyev; A A Chepurnov; S V Netesov
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

4.  Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995.

Authors:  Y Guimard; M A Bwaka; R Colebunders; P Calain; M Massamba; A De Roo; K D Mupapa; K Kibadi; K J Kuvula; D E Ndaberey; K R Katwiki; B B Mapanda; O B Nkuku; Y Fleerackers; E Van den Enden; M A Kipasa
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

5.  The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit.

Authors:  A S Khan; F K Tshioko; D L Heymann; B Le Guenno; P Nabeth; B Kerstiëns; Y Fleerackers; P H Kilmarx; G R Rodier; O Nkuku; P E Rollin; A Sanchez; S R Zaki; R Swanepoel; O Tomori; S T Nichol; C J Peters; J J Muyembe-Tamfum; T G Ksiazek
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

6.  Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995.

Authors:  L L Rodriguez; A De Roo; Y Guimard; S G Trappier; A Sanchez; D Bressler; A J Williams; A K Rowe; J Bertolli; A S Khan; T G Ksiazek; C J Peters; S T Nichol
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

7.  Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients.

Authors:  M A Bwaka; M J Bonnet; P Calain; R Colebunders; A De Roo; Y Guimard; K R Katwiki; K Kibadi; M A Kipasa; K J Kuvula; B B Mapanda; M Massamba; K D Mupapa; J J Muyembe-Tamfum; E Ndaberey; C J Peters; P E Rollin; E Van den Enden; E Van den Enden
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

8.  Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.

Authors:  K Mupapa; M Massamba; K Kibadi; K Kuvula; A Bwaka; M Kipasa; R Colebunders; J J Muyembe-Tamfum
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

9.  Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections.

Authors:  P B Jahrling; T W Geisbert; J B Geisbert; J R Swearengen; M Bray; N K Jaax; J W Huggins; J W LeDuc; C J Peters
Journal:  J Infect Dis       Date:  1999-02       Impact factor: 5.226

10.  Ebola haemorrhagic fever among hospitalised children and adolescents in northern Uganda: epidemiologic and clinical observations.

Authors:  E Mupere; O F Kaducu; Z Yoti
Journal:  Afr Health Sci       Date:  2001-12       Impact factor: 0.927

View more
  10 in total

Review 1.  Neurological Complications of Ebola Virus Infection.

Authors:  Bridgette Jeanne Billioux; Bryan Smith; Avindra Nath
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

2.  Association between treatment with oral third-generation cephalosporin antibiotics and mortality outcomes in Ebola virus disease: a multinational retrospective cohort study.

Authors:  Adam R Aluisio; Shiromi M Perera; Derrick Yam; Stephanie Garbern; Jillian L Peters; Logan Abel; Daniel K Cho; Dayan Woldemichael; Stephen B Kennedy; Moses Massaquoi; Foday Sahr; Tao Liu; Adam C Levine
Journal:  Trop Med Int Health       Date:  2020-01-22       Impact factor: 2.622

3.  Assessment of Healthcare Worker Protocol Deviations and Self-Contamination During Personal Protective Equipment Donning and Doffing.

Authors:  Jennie H Kwon; Carey-Ann D Burnham; Kimberly A Reske; Stephen Y Liang; Tiffany Hink; Meghan A Wallace; Angela Shupe; Sondra Seiler; Candice Cass; Victoria J Fraser; Erik R Dubberke
Journal:  Infect Control Hosp Epidemiol       Date:  2017-06-13       Impact factor: 3.254

4.  Neurological Complications and Sequelae of Ebola Virus Disease.

Authors:  Bridgette Jeanne Billioux
Journal:  Curr Infect Dis Rep       Date:  2017-05       Impact factor: 3.663

5.  The natural history of acute Ebola Virus Disease among patients managed in five Ebola treatment units in West Africa: A retrospective cohort study.

Authors:  Kelly Skrable; Reshma Roshania; Michaela Mallow; Vanessa Wolfman; Matthew Siakor; Adam C Levine
Journal:  PLoS Negl Trop Dis       Date:  2017-07-19

6.  Reflections on the Ebola Public Health Emergency of International Concern, Part 1: Post-Ebola Syndrome: The Silent Outbreak.

Authors:  Stanislaw P Stawicki; Richard P Sharpe; Sagar C Galwankar; Joan Sweeney; Noel Martins; Thomas J Papadimos; Donald Jeanmonod; Michael S Firstenberg; Lorenzo Paladino; Bhakti Hansoti; Manish Garg
Journal:  J Glob Infect Dis       Date:  2017 Apr-Jun

Review 7.  New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility.

Authors:  David J Weber; Emily E Sickbert-Bennett; Hajime Kanamori; William A Rutala
Journal:  Am J Infect Control       Date:  2019-06       Impact factor: 2.918

8.  CDC Safety Training Course for Ebola Virus Disease Healthcare Workers.

Authors:  Rupa Narra; Jeremy Sobel; Catherine Piper; Deborah Gould; Nahid Bhadelia; Mary Dott; Anthony Fiore; William A Fischer; Mary Jo Frawley; Patricia M Griffin; Douglas Hamilton; Barbara Mahon; Satish K Pillai; Emily F Veltus; Robert Tauxe; Michael Jhung
Journal:  Emerg Infect Dis       Date:  2017-12       Impact factor: 6.883

Review 9.  Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9).

Authors:  David J Weber; William A Rutala; William A Fischer; Hajime Kanamori; Emily E Sickbert-Bennett
Journal:  Am J Infect Control       Date:  2016-05-02       Impact factor: 2.918

10.  Reasons for and barriers to biosafety and biosecurity training in health-related organizations in Africa, Middle East and Central Asia: findings from GIBACHT training needs assessments 2018-2019.

Authors:  Elizeus Rutebemberwa; Fortress Yayra Aku; Eva Inam Kayed Al Zein; Hedia Bellali
Journal:  Pan Afr Med J       Date:  2020-09-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.